Bevacizab 400 mg Injection
  1. Home
  2. Pharma Products
  3. Abbott
  4. Bevacizab 400 mg Injection

Bevacizab 400 mg Injection

Bevacizab 400 mg Injection contains bevacizumab and is an anticancer medicine used for the treatment of certain cancers. It is supplied as a 400 mg/16 mL solution for intravenous infusion. The medicine works by blocking VEGF, which helps reduce the formation of blood vessels that support tumor growth.

BUY NOW

Category

Bevacizab 400 mg Injection is a monoclonal antibody that targets vascular endothelial growth factor to inhibit tumor angiogenesis. It may be used in the treatment of cancers such as colorectal, lung, kidney, ovarian, cervical, and certain brain cancers according to the prescribed treatment regimen. The dose and duration depend on the cancer type, treatment protocol, and clinical response. Administration should be performed as an intravenous infusion under the supervision of qualified healthcare professionals.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 400 mg/16 mL
Dosage Form Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 16 mL Vial
Storage 2°C–8°C, Do Not Freeze

Product Also Known As

Bevacizab 400 mg Injection, Bevacizab 400 mg/16 mL Injection, Bevacizumab 400 mg Injection, Bevacizumab Solution for Infusion, Bevacizab Cancer Injection, Bevacizumab Anticancer Injection